WG
NAGE

Winton Group’s Niagen Bioscience NAGE Stock Holding History

Winton Group’s Portfolio NAGE Stock Details NAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-19,155
Closed -$102K – 814
2024
Q4 		$102K Sell
19,155
-158,923
-89% -$870K 0.01% 581
2024
Q3 		$650K Sell
178,078
-40,779
-19% -$128K 0.05% 399
2024
Q2 		$597K Buy
+218,857
New +$732K 0.04% 401
2019
Q4 		– Sell
-32,037
Closed -$126K – 1797
2019
Q3 		$126K Buy
+32,037
New +$137K ﹤0.01% 1443

Other funds holding NAGE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TCM
Tieton Capital Management Yakima, Washington $299M AUM 54.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Winton Group's NAGE Position: Q1 2025 in Review

Winton Group sold out of Niagen Bioscience (NAGE) in Q1 2025, closing a stake of 19,155 shares — an estimated $102K sold.

Winton Group first reported a position in NAGE in Q3 2019 and held it in 4 quarters. The position peaked at $650K in Q3 2024. 139 funds tracked by Wall St. Rank hold NAGE as of Q1 2025.

  • Winton Group reported no remaining Niagen Bioscience position as of Q1 2025 after selling out during the quarter.
  • Winton Group sold 19,155 Niagen Bioscience shares in Q1 2025, an estimated $102K.
  • Winton Group first reported a position in Niagen Bioscience in Q3 2019 and held it in 4 quarters.
  • Winton Group's Niagen Bioscience position peaked at $650K in Q3 2024.
  • 139 funds tracked by Wall St. Rank held Niagen Bioscience as of Q1 2025.

Based on Winton Group's 13F filing for Q1 2025, filed 15 May 2025.